The United States Food and Drug Administration (USFDA) has inspected Neuland Laboratories’ Unit 2 manufacturing facility, located at Pashamylaram village, Sangareddy District, in Telangana from April 28, 2025 to May 2, 2025.
The FDA issued Form 483, with one observation related to building and facility management, which the company will respond to within the stipulated timelines.
Neuland Laboratories is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1660.25 |
| Dr. Reddys Lab | 1214.95 |
| Cipla | 1227.85 |
| Zydus Lifesciences | 928.65 |
| Lupin | 2297.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: